Biomerica Income Statement

Financials in millions USD. Fiscal year is June - May.

Millions USD. Fiscal year is Jun - May.

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Revenue	4.45	5.31	5.42	5.34	18.87
Revenue Growth	-16.16%	-1.92%	1.42%	-71.71%	162.13%
Cost of Revenue	4.09	4.81	4.8	4.89	15.89
Gross Profit	0.36	0.5	0.61	0.45	2.98
Selling, General & Admin	4.89	4.61	5.49	6.09	5.7
Research & Development	0.79	1.02	1.49	1.58	1.81
Operating Expenses	5.68	5.64	6.98	7.67	7.51
Operating Income	-5.32	-5.14	-6.37	-7.22	-4.53
Interest & Investment Income	0.13	0.17	0.43	0.13	0.03
Other Non Operating Income (Expenses)	-	-	-	0	-
EBT Excluding Unusual Items	-5.19	-4.97	-5.94	-7.09	-4.51
Gain (Loss) on Sale of Investments	0.34	-	-	-	-
Other Unusual Items	1.1	-	-	-	-
Pretax Income	-3.75	-4.97	-5.94	-7.09	-4.51
Income Tax Expense	0.02	0	0.04	0.05	0.02
Net Income	-3.78	-4.97	-5.98	-7.14	-4.53
Net Income to Common	-3.78	-4.97	-5.98	-7.14	-4.53
Net Income Growth	-	-	-	-	-
Shares Outstanding (Basic)	3	2	2	2	2
Shares Outstanding (Diluted)	3	2	2	2	2
Shares Change	26.90%	9.22%	18.87%	11.69%	6.24%
EPS (Basic)	-1.30	-2.16	-2.84	-4.04	-2.86
EPS (Diluted)	-1.30	-2.16	-2.84	-4.04	-2.88
EPS Growth	-	-	-	-	-

Additional Metrics

Fiscal Year	FY 2026	FY 2025	FY 2024	FY 2023	FY 2022
Period Ending	May '26 May 31, 2026	May '25 May 31, 2025	May '24 May 31, 2024	May '23 May 31, 2023	May '22 May 31, 2022
Free Cash Flow	-3.42	-3.84	-5.41	-5.54	-0.54
Free Cash Flow Per Share	-1.17	-1.67	-2.57	-3.13	-0.34
Gross Margin	8.13%	9.38%	11.28%	8.35%	15.78%
Operating Margin	-119.47%	-96.72%	-117.58%	-135.29%	-24.03%
Profit Margin	-84.77%	-93.64%	-110.40%	-133.73%	-24.01%
Free Cash Flow Margin	-76.83%	-72.34%	-99.94%	-103.73%	-2.84%
EBITDA	-5.24	-5.05	-6.29	-7.14	-4.2
EBITDA Margin	-117.74%	-95.09%	-116.08%	-133.71%	-22.23%
D&A For EBITDA	0.08	0.09	0.08	0.08	0.34
EBIT	-5.32	-5.14	-6.37	-7.22	-4.53
EBIT Margin	-119.47%	-96.72%	-117.58%	-135.29%	-24.03%
Advertising Expenses	0.04	0.04	0.1	0.16	0.08

SEC Filings: 10-K · 10-Q